Hannah W Song Robert P Somerville David F Stroncek Steven L Highfill
10.1080/08830185.2022.2067154
Int Rev Immunol
2022;41(6):638-648.
car t cells cell therapy gmp manufacturing process development tcr t cells
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/35486592/
Neoplasms / therapy Receptors, Antigen, T-Cell / genetics
Neoplasms / therapy Receptors, Antigen, T-Cell / genetics Research Support, N.I.H., Intramural B-Lymphocytes Humans Immunotherapy, Adoptive T-Lymphocytes Receptors, Antigen, T-Cell
PMC9815724
35486592
Scaling up and scaling out: Advances and challenges in manufacturing engineered T cell therapies
2022